About: Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована в січні 2000 (uk) article scientifique publié en 2000 (fr) im Januar 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2000 (ast) articolo scientifico (pubblicato il 2000) (it) artikull shkencor i botuar më 01 janar 2000 (sq) scientific article published on 01 January 2000 (en) գիտական հոդված հրատարակված 2000 թվականի հունվարի 1-ին (hy)
publication date	wds:Q73409370-3F6F32CA-6F60-4C4D-8B13-B082578E8D3C
publication date	2000-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73409370-02905B55-8B6F-465A-94EF-896B65601744 wds:Q73409370-368FE05C-7230-453D-8C14-27A209A3A026 wds:Q73409370-3C5E51DD-C4C2-45B0-9C70-A75B80AF8103 wds:Q73409370-40FF91C5-3218-4855-A1C2-381120FC86F6 wds:Q73409370-501A6EA1-C796-468B-9753-D61AEF7EB678 wds:Q73409370-9005A569-4F8E-4F81-B615-16204368D055 wds:Q73409370-B1C8B10D-5BA3-4596-B30C-5F3322BAF624 wds:Q73409370-C31CAA72-EDC7-41F0-AF9F-8D8B401AD107 wds:Q73409370-ED4E67F8-1DE3-4E77-AA56-F9D79AD4F0AC wds:Q73409370-F0A4BFD4-9D25-4C22-9AC8-B11F57F1E7CA wds:Q73409370-F7A947CB-C523-4A80-AA20-C803B9B45510 wds:Q73409370-FD139A57-C41B-4016-8E13-0FA5831C0885
cites work	Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg) High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates Interleukin 2 immediately after autologous bone marrow transplantation for acute lymphoblastic leukemia--a phase I study Evaluation of mobilized CD34+ cell counts to guide timing and yield of large-scale collection by leukapheresis. High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer
author name string	wds:Q73409370-23CC9DEA-4AC1-4BB7-A2F9-2406FBA9EA18 wds:Q73409370-71ED21F1-F45F-4A2B-A2BC-5271A8CE5E55 wds:Q73409370-9098C80C-B78B-4403-90BA-27611F873286 wds:Q73409370-B43999E7-CB5A-4661-9803-F87EBFC22AF9 wds:Q73409370-C595F981-ADCA-4616-8537-D0B10CBF3713 wds:Q73409370-DAA5CA96-8955-4442-BDEA-3481E4FC1569
author name string	D J Weisdorf L J Burns T E DeFor C Hummer K M Ogle T L Repka
rdfs:label	Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (en) Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (nl) Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (sq)
skos:prefLabel	Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (en) Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (nl) Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (sq)
name	Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (en) Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (nl) Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (sq)
author	wds:Q73409370-FC9FD2CD-ED90-4C3F-B3D8-B021FFEEC4C6
author	Jeffrey S. Miller
title	wds:Q73409370-EBC053A2-87AE-4B22-88EB-4B9784041C62
title	Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (en)
page(s)	wds:Q73409370-31C4F658-9E8B-42E1-B997-B92BFE73DF0B
page(s)	96-103
instance of	wds:Q73409370-498A5B64-EDDC-4201-8FC9-A6A1BB75F807
instance of	scholarly article
PubMed ID	wds:Q73409370-575A6462-DFFF-4648-8F01-1D315EB72523
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10658681
PubMed ID	10658681
published in	wds:Q73409370-C829CD78-782F-47D6-AFC8-9188C0635590
published in	Experimental Hematology
issue	wds:Q73409370-B8F166A4-3CC0-462B-B6F0-30864DDBBCB6
volume	wds:Q73409370-5FF96441-D5E8-4EF5-B54F-C6DACA245603
issue	1
volume	28
DOI	wds:Q73409370-C08089E8-D1B5-48F7-9A0E-B32AD150E989
DOI	http://dx.doi.org/10.1016/S0301-472X(99)00129-0
DOI	10.1016/S0301-472X(99)00129-0
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73409370
is cites work of	New aspects of natural-killer-cell surveillance and therapy of cancer Biological role of NK cells and immunotherapeutic approaches in breast cancer The CD3- 16+ 56+ NK cell count independently predicts autologous blood stem cell mobilization Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant. Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer Treatment of breast cancer with chemotherapy in combination with filgrastim: approaches to improving therapeutic outcome Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients. Comparative study and effects of macrophage colony-stimulating factor (M-CSF) administration on NK1.1+ cells in mouse spleen and bone marrow
is cites work of	wds:Q43731620-D7EEAE6E-DF57-479C-A2BD-AA9A6C3EB0D8 wds:Q40371959-C8EABA18-9A7D-4780-A910-D693F95F3F16 wds:Q51990914-1CD163E0-E57D-4FDC-B3D9-D48B040ACE57 wds:Q35024456-9B93C52B-02A3-4E29-B395-3844832603AD wds:Q37222064-BB25C782-A6E2-4500-9C8D-A3C9437F6F4E wds:Q77462807-50235640-A9D2-4EFB-9E84-981121FDEEDC wds:Q36460884-6A2DB91D-06EA-43E2-B511-87D807704A81 wds:Q38469030-E06D631E-27C4-4C72-9382-C37B38C57D87 wds:Q53925120-45500E0F-D751-4B84-AB85-B0689472C2C2 wds:Q34988265-8F003214-CD13-4BF2-8410-DE0ACCFB29AF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software